Software · Post Line
Anitoa Systems, LLC, a Silicon Valley biotechnology company, has announced a major advancement in point-of-care molecular testing. Their highly popular line of portable qPCR instruments now features comprehensive cloud connectivity and enterprise-grade security. This innovation empowers researchers, clinicians, and public health officials with unprecedented flexibility and data accessibility, accelerating the fight against infectious diseases through real-time monitoring and centralized data storage.
Users can now remotely access and control their Anitoa instruments via a secure HTTPS interface through a customizable, cross-platform web application. This allows for seamless data collection, remote experiment setup, and real-time monitoring from anywhere globally. The devices are designed to be easily controlled without physical tethering, ensuring efficient diagnostic workflows.
The integration of cloud connectivity enables transformative applications in global health and research. By feeding diagnostic data into large-scale analytics platforms and supporting AI integration, Anitoa’s instruments facilitate real-time aggregation of diagnostic data across multiple sites. This capability helps identify emerging pathogen trends and enables rapid, data-driven responses to outbreaks globally.
Anitoa has incorporated robust, hardware-level encryption into the devices, ensuring data privacy and security from collection to cloud transmission. The dedicated hardware security root of trust module makes the instruments tamper-proof and physically unclonable, safeguarding user information and patient data.
Anitoa’s portable qPCR devices redefine decentralized molecular diagnostics with their fast, cost-effective, and portable design. Powered by proprietary ultra-low-light CMOS bioimaging sensors, these devices replace traditional bulky and costly photon-multiplier tube (PMT) and CCD optics, targeting infectious pathogens in humans, food, and the environment.
Anitoa Systems, established in 2013 with headquarters in Sunnyvale, California, focuses on developing highly integrated CMOS bio-sensors for fluorescence and chemiluminescence molecular imaging. Their mission is to provide accessible, life-saving diagnostic systems to remote regions worldwide.
Source: morningstar.com
